These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2473538)

  • 1. Epitope localization of anti-factor VIII monoclonal antibodies determined by recombinant peptides.
    Ware J; Toomey JR; Stafford DW
    Thromb Haemost; 1989 Apr; 61(2):225-9. PubMed ID: 2473538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.
    Ginsburg D; Bockenstedt PL; Allen EA; Fox DA; Foster PA; Ruggeri ZM; Zimmerman TS; Montgomery RR; Bahou WF; Johnson TA
    Thromb Haemost; 1992 Jan; 67(1):166-71. PubMed ID: 1377414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.
    Ware J; Toomey JR; Stafford DW
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3165-9. PubMed ID: 2452445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
    Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting.
    Scandella D; Timmons L; Mattingly M; Trabold N; Hoyer LW
    Thromb Haemost; 1992 Jun; 67(6):665-71. PubMed ID: 1509407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S; Gaucher C; Piétu G; Chérel G; Meyer D; Mazurier C
    Br J Haematol; 1994 May; 87(1):113-8. PubMed ID: 7524613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
    Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.
    Bahou WF; Ginsburg D; Sikkink R; Litwiller R; Fass DN
    J Clin Invest; 1989 Jul; 84(1):56-61. PubMed ID: 2472430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
    Scandella D
    Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
    Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
    Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain.
    Takamiya O
    Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
    Stephen CW; Helminen P; Lane DP
    J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
    Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
    Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G; Ribba AS; Chérel G; Siguret V; Obert B; Rouault C; Ginsburg D; Meyer D
    Thromb Haemost; 1994 Jun; 71(6):788-92. PubMed ID: 7974349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.